Urine Epidermal Growth Factor and Kidney Function Decline in Middle-Aged Adults

IF 3.2 Q1 UROLOGY & NEPHROLOGY
Merve Postalcioglu , Rebecca Scherzer , Joachim H. Ix , David R. Jacobs Jr , Cora E. Lewis , Sucheta Vaigankar , Michelle M. Estrella , Orlando M. Gutierrez , Michael G. Shlipak
{"title":"Urine Epidermal Growth Factor and Kidney Function Decline in Middle-Aged Adults","authors":"Merve Postalcioglu ,&nbsp;Rebecca Scherzer ,&nbsp;Joachim H. Ix ,&nbsp;David R. Jacobs Jr ,&nbsp;Cora E. Lewis ,&nbsp;Sucheta Vaigankar ,&nbsp;Michelle M. Estrella ,&nbsp;Orlando M. Gutierrez ,&nbsp;Michael G. Shlipak","doi":"10.1016/j.xkme.2024.100846","DOIUrl":null,"url":null,"abstract":"<div><h3>Rationale &amp; Objective</h3><p>The diagnosis and prognostication of chronic kidney disease (CKD) largely rely on glomerular measures that may not reflect tubular damage. We investigated the associations of urine kidney tubule biomarkers with estimated glomerular filtration rate (eGFR) change among middle-aged adults, when chronic diseases typically emerge.</p></div><div><h3>Study Design</h3><p>An observational cohort study.</p></div><div><h3>Setting &amp; Participants</h3><p>A total of 1,145 participants of the Coronary Artery Risk Development in Young Adults (CARDIA) study without CKD, hypertension, or cardiovascular disease at the year 20 visit.</p></div><div><h3>Exposures</h3><p>Seven different biomarkers of tubular health: urine epidermal growth factor (EGF), alpha-1-microglobulin (α1m), interleukin-18, kidney injury molecule-1, monocyte chemoattractant protein-1, uromodulin, and chitinase-3-like protein 1.</p></div><div><h3>Outcomes</h3><p>Ten-year eGFR change and incident reduced eGFR (new onset of eGFR<!--> <!-->&lt;<!--> <!-->60<!--> <!-->mL/min/1.73<!--> <!-->m<sup>2</sup>).</p></div><div><h3>Analytical Approach</h3><p>We examined associations of tubular health biomarkers with 10-year eGFR change and incident reduced eGFR with linear mixed models and interval-censored proportional hazards regression models, respectively. Both minimally and fully adjusted models were controlled for urine creatinine levels.</p></div><div><h3>Results</h3><p>The mean age of participants was 44.8<!--> <!-->±<!--> <!-->3.7 years, with 39% African American and 56% female. The average 10-year change in eGFR was -18.6<!--> <!-->mL/min/1.73<!--> <!-->m<sup>2</sup> (95% CI, -19.4 to -17.8). In contrast to the other tubular biomarkers, which showed conflicting results, EGF demonstrated strong, consistent associations with both kidney outcomes. Each 1-standard deviation (SD) higher EGF was associated with a 2.37<!--> <!-->mL/min/1.73<!--> <!-->m<sup>2</sup> (95% CI, 0.64-4.10) smaller 10-year decrease in eGFR and a 42% (95% CI, 4%-64%) lower risk of incident reduced eGFR in the fully adjusted model.</p></div><div><h3>Limitations</h3><p>Observational design, measurements of eGFR were done only at 5-year intervals during follow-up.</p></div><div><h3>Conclusions</h3><p>In middle-aged, community-dwelling adults without hypertension, cardiovascular disease or CKD, higher urine EGF concentrations are associated with slower eGFR decline, whereas other kidney tubule biomarkers lacked a consistent association with kidney function decline.</p></div><div><h3>Plain Language Summary</h3><p>Current measures of chronic kidney disease (CKD) rely on markers of glomerular health and function. This approach inadequately captures the role of kidney tubule health, a known histopathological predictor of CKD development. We investigated associations of 7 biomarkers of kidney tubule health with 10-year estimated glomerular filtration rate (eGFR) change and incident reduced eGFR. Among 7 biomarkers, only epidermal growth factor showed persistent and inverse associations with both 10-year eGFR change and incident reduced eGFR. These findings suggest that epidermal growth factor has an association with kidney function changes and might play a protective role in kidney disease development.</p></div>","PeriodicalId":17885,"journal":{"name":"Kidney Medicine","volume":null,"pages":null},"PeriodicalIF":3.2000,"publicationDate":"2024-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590059524000578/pdfft?md5=63afe19094ca813342c047a024fd52cf&pid=1-s2.0-S2590059524000578-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kidney Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590059524000578","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Rationale & Objective

The diagnosis and prognostication of chronic kidney disease (CKD) largely rely on glomerular measures that may not reflect tubular damage. We investigated the associations of urine kidney tubule biomarkers with estimated glomerular filtration rate (eGFR) change among middle-aged adults, when chronic diseases typically emerge.

Study Design

An observational cohort study.

Setting & Participants

A total of 1,145 participants of the Coronary Artery Risk Development in Young Adults (CARDIA) study without CKD, hypertension, or cardiovascular disease at the year 20 visit.

Exposures

Seven different biomarkers of tubular health: urine epidermal growth factor (EGF), alpha-1-microglobulin (α1m), interleukin-18, kidney injury molecule-1, monocyte chemoattractant protein-1, uromodulin, and chitinase-3-like protein 1.

Outcomes

Ten-year eGFR change and incident reduced eGFR (new onset of eGFR < 60 mL/min/1.73 m2).

Analytical Approach

We examined associations of tubular health biomarkers with 10-year eGFR change and incident reduced eGFR with linear mixed models and interval-censored proportional hazards regression models, respectively. Both minimally and fully adjusted models were controlled for urine creatinine levels.

Results

The mean age of participants was 44.8 ± 3.7 years, with 39% African American and 56% female. The average 10-year change in eGFR was -18.6 mL/min/1.73 m2 (95% CI, -19.4 to -17.8). In contrast to the other tubular biomarkers, which showed conflicting results, EGF demonstrated strong, consistent associations with both kidney outcomes. Each 1-standard deviation (SD) higher EGF was associated with a 2.37 mL/min/1.73 m2 (95% CI, 0.64-4.10) smaller 10-year decrease in eGFR and a 42% (95% CI, 4%-64%) lower risk of incident reduced eGFR in the fully adjusted model.

Limitations

Observational design, measurements of eGFR were done only at 5-year intervals during follow-up.

Conclusions

In middle-aged, community-dwelling adults without hypertension, cardiovascular disease or CKD, higher urine EGF concentrations are associated with slower eGFR decline, whereas other kidney tubule biomarkers lacked a consistent association with kidney function decline.

Plain Language Summary

Current measures of chronic kidney disease (CKD) rely on markers of glomerular health and function. This approach inadequately captures the role of kidney tubule health, a known histopathological predictor of CKD development. We investigated associations of 7 biomarkers of kidney tubule health with 10-year estimated glomerular filtration rate (eGFR) change and incident reduced eGFR. Among 7 biomarkers, only epidermal growth factor showed persistent and inverse associations with both 10-year eGFR change and incident reduced eGFR. These findings suggest that epidermal growth factor has an association with kidney function changes and might play a protective role in kidney disease development.

尿液表皮生长因子与中年人肾功能衰退
理论依据和研究目标慢性肾脏病(CKD)的诊断和预后在很大程度上依赖于肾小球指标,而这些指标可能无法反映肾小管的损伤。我们调查了尿液肾小管生物标志物与中年人估计肾小球滤过率(eGFR)变化之间的关系,因为中年人通常在慢性疾病出现时尿液肾小管生物标志物会发生变化。暴露七种不同的肾小管健康生物标志物:尿液表皮生长因子(EGF)、α-1-微球蛋白(α1m)、白细胞介素-18、肾损伤分子-1、单核细胞趋化蛋白-1、尿调节蛋白和甲壳素酶-3样蛋白1。分析方法我们分别采用线性混合模型和区间删失比例危险回归模型研究了肾小管健康生物标志物与 10 年 eGFR 变化和事件性 eGFR 下降之间的关系。结果参与者的平均年龄为(44.8 ± 3.7)岁,非裔美国人占 39%,女性占 56%。10 年间 eGFR 平均变化为 -18.6 mL/min/1.73 m2(95% CI,-19.4 至 -17.8)。其他肾小管生物标志物显示的结果相互矛盾,相比之下,表皮生长因子与两种肾脏结果都显示出强烈、一致的关联性。在完全调整模型中,EGF 每增加 1 个标准差 (SD) 就会导致 10 年 eGFR 下降 2.37 mL/min/1.73 m2(95% CI,0.64-4.10),eGFR 下降的风险降低 42%(95% CI,4%-64%)。结论在没有高血压、心血管疾病或慢性肾脏病的社区居住的中年成人中,尿液中 EGF 浓度越高,eGFR 下降越慢,而其他肾小管生物标志物与肾功能下降没有一致的联系。这种方法不能充分反映肾小管健康的作用,而肾小管健康是已知的慢性肾脏病发展的组织病理学预测因子。我们研究了肾小管健康的 7 个生物标志物与 10 年估计肾小球滤过率(eGFR)变化和事件性 eGFR 降低的关系。在这7种生物标志物中,只有表皮生长因子与10年eGFR变化和事件性eGFR降低呈持续的反向关系。这些研究结果表明,表皮生长因子与肾功能变化有关,并可能在肾脏疾病的发展过程中起到保护作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Kidney Medicine
Kidney Medicine Medicine-Internal Medicine
CiteScore
4.80
自引率
5.10%
发文量
176
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信